Continuous Glucose Monitoring Market, By Component Type, By Modality, By Product Type, By Patient Type, By Distribution Channel, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Continuous Glucose Monitoring Market size was valued at USD 11,329.32 Million in 2023, expanding at a CAGR of 12.79% from 2024 to 2032.

The Continuous Glucose Monitoring (CGM) market refers to the sector that develops and supplies devices designed to track glucose levels in real-time throughout the day and night. These devices are primarily used by individuals with diabetes to manage their blood sugar levels more effectively, reducing the need for frequent fingerstick testing. CGMs work by using a sensor placed under the skin to measure glucose in the interstitial fluid, transmitting data to a receiver or smartphone. The market has seen significant growth due to rising diabetes prevalence, increasing awareness about diabetes management, and technological advancements that have made CGMs more accurate, affordable, and user-friendly. CGMs also offer features like alerts for hypo- or hyperglycemia and integration with insulin pumps, providing enhanced control. As healthcare systems emphasize preventative care, the demand for CGMs is expected to continue rising, creating opportunities for innovation and expansion in the market.

Continuous Glucose Monitoring Market- Market Dynamics

Non-invasive glucose monitoring technologies offer more comfortable, convenient alternatives.

Non-invasive glucose monitoring technologies are gaining momentum due to their potential to offer more comfortable, convenient alternatives to traditional fingerstick testing. Key drivers for the Continuous Glucose Monitoring Market include advancements in biosensor technology, which are enabling more accurate and reliable measurements without the need for skin penetration. Non-invasive methods, such as monitoring through sweat, tears, or infrared light, reduce discomfort and the risk of infection, which appeals to patients who require frequent monitoring. Furthermore, the growing preference for painless, user-friendly devices among diabetic patients and healthcare providers is fueling adoption.

Non-invasive technologies also promise to broaden the appeal of glucose monitoring to a wider range of users, including those at risk of developing diabetes. The convenience of these systems can improve patient compliance and enhance overall disease management. According to the National Institutes of Health (NIH), an estimated 1 in 3 American adults is at risk of developing diabetes, further driving the demand for more accessible and less invasive monitoring solutions. With increasing government and academic support for non-invasive technologies, the market is poised for growth as researchers explore more innovative solutions for diabetes management.

Continuous Glucose Monitoring Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.79% over the forecast period (2024-2032)

Based on Component Type segmentation, Sensors was the leading segment in 2023

Based on Modality segmentation, Invasive was the leading segment in 2023

Based on Product Type segmentation, Continuous Glucose Monitoring Systems (CGMS) was predicted to show maximum market share in the year 2023

Based on Patient Type segmentation, Type 1 diabetes was the leading segment in 2023

Based on Distribution Channel segmentation, Retail Sales was the leading segment in 2023

based on Region, North America was the leading revenue generator in 2023

Continuous Glucose Monitoring Market- Segmentation Analysis:

The Global Continuous Glucose Monitoring Market is segmented based on Component Type, Modality, Product Type, Patient Type, Distribution Channel, and Region.

The market is divided into two categories based on Product Type: Continuous Glucose Monitoring Systems (CGMS) and Self-Monitoring Blood Glucose Systems (SMBG). In the Continuous Glucose Monitoring Systems (CGMS) market, the dominant segment is the wearable CGMS, particularly the sensor-based devices. These systems provide real-time, continuous glucose data, offering significant benefits for patients with diabetes, especially those with Type 1 diabetes. The growing demand for more accurate, user-friendly, and minimally invasive solutions has driven the adoption of wearable CGMS, which can be integrated with smartphones or insulin pumps for automated data tracking and management. This technology not only enhances patient convenience but also improves glycemic control, making it a key driver in the market's growth.

The market is divided into two categories based on Modality: Invasive CGM and Non-Invasive CGM. Invasive Continuous Glucose Monitoring (CGM) systems are the most dominant segment in the market. These systems involve a subcutaneous sensor that continuously monitors glucose levels in real time, providing accurate and reliable data. They offer key features such as alerts for hypo- or hyperglycemia, and integration with insulin pumps and smartphones. The dominance of invasive CGMs is due to their proven accuracy, extensive regulatory approvals, and strong market presence from leading manufacturers. Despite the ongoing development of non-invasive systems, invasive CGMs remain the preferred choice for managing diabetes effectively.

Continuous Glucose Monitoring Market- Geographical Insights

The North American landscape for the Continuous Glucose Monitoring (CGM) market is rapidly expanding, driven by rising incidences of diabetes and increasing awareness about the importance of glucose management. The U.S. holds the largest share, with both Type 1 and Type 2 diabetes patients increasingly adopting CGM systems due to their ability to provide real-time data, improve glycemic control, and reduce complications. Advancements in technology, such as smaller, more affordable, and user-friendly devices, are also fueling market growth. The integration of CGM devices with mobile apps and other digital health solutions is further enhancing their appeal. Moreover, the growing prevalence of diabetes-related complications, coupled with the push for preventive healthcare, is creating a strong demand for CGM systems. Regulatory approvals from bodies like the FDA and favorable reimbursement policies are further accelerating adoption. As healthcare systems prioritize chronic disease management and personalized medicine, the market is expected to see continued growth in both the U.S. and Canada.

Continuous Glucose Monitoring Market- Competitive Landscape:

The competitive landscape of the Continuous Glucose Monitoring (CGM) market is characterized by a mix of established players and emerging companies focused on innovative diabetes management solutions. Leading companies like Abbott, Dexcom, and Medtronic dominate the market, with their advanced CGM systems offering real-time glucose monitoring, integration with insulin pumps, and mobile app connectivity. Abbott's FreeStyle Libre and Dexcom's G6/G7 systems are among the most widely used. Medtronic also maintains a strong position with its Guardian Connect system. Newer entrants like Senseonics, with its implantable Eversense CGM, bring unique solutions to the market, offering longer sensor life. The market is highly competitive with companies competing on factors like sensor accuracy, ease of use, pricing, and patient data management capabilities. Partnerships between CGM manufacturers and pharmaceutical or tech companies, such as insulin providers or mobile health apps, further intensify competition, driving innovation and growth in the market. Furthermore, regulatory approval and reimbursement policies are crucial in shaping the competitive dynamics.

Recent Developments:

In February 2024, Dexcom, Inc. introduces Dexcom ONE+, the latest Continuous Glucose Monitoring (CGM), to strengthen strong, new diabetes care technologies for patients in Belgium, Spain, and Poland.

In January 2024, Abbott and Tandem Diabetes Care, Inc., a player in insulin delivery and diabetes technologies, unveiled the t: slim X2 insulin pump with Control-IQ technology, making it the first automated insulin administration system in the United States to combine with the FreeStyle Libre 2 Plus sensor. This enabled the organization to strengthen its product portfolio.

In January 2024, Medtronic got CE approval for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one Continuous Glucose Monitor (CGM) that does not require fingersticks or overtape, to strengthen its product line. to bring

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Dexcom, Inc.
Medtronic plc
Senseonics Holdings, Inc.
Roche Diagnostics
LifeScan, Inc.
Ascensia Diabetes Care
Tandem Diabetes Care, Inc.
Insulet Corporation
Ypsomed Holding AG
Johnson & Johnson
GlucoWise
Beta Bionics
Pear Therapeutics
Diasend
F. Hoffmann-La Roche AG
Novo Nordisk A/S
Glooko, Inc.

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY COMPONENT TYPE- MARKET ANALYSIS, 2019 - 2032

Transmitters and Receivers
Sensors

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

Non-invasive
Invasive

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Self-Monitoring Blood Glucose (SMBG) Systems
Continuous Blood Glucose Monitoring (CBGM) Systems

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

Type-1 Diabetes
Type-2 Diabetes

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

Institutional Sales
Retail Sales
Others

GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4256

1. Continuous Glucose Monitoring Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Continuous Glucose Monitoring Market Snippet by Component Type
- 2.1.2. Continuous Glucose Monitoring Market Snippet by Modality
- 2.1.3. Continuous Glucose Monitoring Market Snippet by Product Type
- 2.1.4. Continuous Glucose Monitoring Market Snippet by Patient Type
- 2.1.5. Continuous Glucose Monitoring Market Snippet by Distribution Channel
- 2.1.6. Continuous Glucose Monitoring Market Snippet by Country
- 2.1.7. Continuous Glucose Monitoring Market Snippet by Region
2.2. Competitive Insights

3. Continuous Glucose Monitoring Key Market Trends

3.1. Continuous Glucose Monitoring Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Continuous Glucose Monitoring Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Continuous Glucose Monitoring Market Opportunities
3.4. Continuous Glucose Monitoring Market Future Trends

4. Continuous Glucose Monitoring Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Continuous Glucose Monitoring Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Continuous Glucose Monitoring Market Landscape

6.1. Continuous Glucose Monitoring Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Continuous Glucose Monitoring Market - By Component Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Component Type, 2023 & 2032 (%)
- 7.1.2. Transmitters and Receivers
- 7.1.3. Sensors

8. Continuous Glucose Monitoring Market - By Modality

8.1. Overview
- 8.1.1. Segment Share Analysis, By Modality, 2023 & 2032 (%)
- 8.1.2. Non-invasive
- 8.1.3. Invasive

9. Continuous Glucose Monitoring Market - By Product Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
  - 9.1.1.1. Self-Monitoring Blood Glucose (SMBG) Systems
  - 9.1.1.2. Continuous Blood Glucose Monitoring (CBGM) Systems

10. Continuous Glucose Monitoring Market - By Patient Type

10.1. Overview
- 10.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
- 10.1.2. Type-1 Diabetes
- 10.1.3. Type-2 Diabetes

11. Continuous Glucose Monitoring Market - By Distribution Channel

11.1. Overview
- 11.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
- 11.1.2. Institutional Sales
- 11.1.3. Retail Sales
- 11.1.4. Others

12. Continuous Glucose Monitoring Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Continuous Glucose Monitoring Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.2.9. The U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Continuous Glucose Monitoring Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Continuous Glucose Monitoring Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Continuous Glucose Monitoring Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Continuous Glucose Monitoring Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Continuous Glucose Monitoring Industry

13.1. Competitive Dashboard
- 13.1.1. Competitive Benchmarking
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Abbott Laboratories
- 13.2.2. Dexcom, Inc.
- 13.2.3. Medtronic plc
- 13.2.4. Senseonics Holdings, Inc.
- 13.2.5. Roche Diagnostics
- 13.2.6. LifeScan, Inc.
- 13.2.7. Ascensia Diabetes Care
- 13.2.8. Tandem Diabetes Care, Inc.
- 13.2.9. Insulet Corporation
- 13.2.10. Ypsomed Holding AG
- 13.2.11. Johnson & Johnson
- 13.2.12. GlucoWise
- 13.2.13. Beta Bionics
- 13.2.14. Pear Therapeutics
- 13.2.15. Diasend
- 13.2.16. F. Hoffmann-La Roche AG
- 13.2.17. Novo Nordisk A/S
- 13.2.18. Glooko, Inc.

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us